Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
These initiatives aim to improve access to healthcare for rare disease patients
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
Rocuronium Bromide Injection is a neuromuscular blocking agent
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
He is a Chartered Accountant with more than 19 years of extensive experience
Subscribe To Our Newsletter & Stay Updated
